(Q44628316)

4 December 2017

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment (English)

1 reference

4 December 2017

3

Jordan W Smoller

1 reference

4 December 2017

1

Roy H Perlis

1 reference

4 December 2017

David Mischoulon

2

1 reference

4 December 2017

Yu-Jui Yvonne Wan

4

1 reference

4 December 2017

Stefania Lamon-Fava

5

1 reference

4 December 2017

Keh-Ming Lin

6

1 reference

4 December 2017

Maurizio Fava

8

1 reference

4 December 2017

Jerrold F. Rosenbaum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14573314

24 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0006322303004244?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00424-4

https://api.elsevier.com/content/article/PII:S0006322303004244?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00424-4

24 March 2024

published in

Biological Psychiatry

1 reference

4 December 2017

54

1 reference

4 December 2017

9

1 reference

4 December 2017

879-883

1 reference

A rating scale for drug-induced akathisia

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Quantitative rating of depressive states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Cloning and expression of a functional serotonin transporter from rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Population studies of polymorphisms of the serotonin transporter protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Allelic Variation of Human Serotonin Transporter Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Serotonin transporter gene polymorphism and antidepressant response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Isolation of a cDNA encoding the human brain serotonin transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Sleep and depression--results from psychobiological studies: an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Sleep and sleep-wake manipulations in bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Pharmacogenetics in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Sleep deprivation in depression: what do we know, where do we go?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

Remission of SSRI-induced akathisia after switch to nefazodone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900424-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Antidepressant noncompliance as a factor in the discontinuation syndrome

17

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00424-4

24 March 2024

Identifiers

1 reference

4 December 2017

1 reference